Historical record - last NADAC publication: 1/4/2017

Product Information

ACTOS 15 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $12.4826 per EA under NDC 64764015104. Its NADAC has been published 216 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the pioglitazone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ACTOS 15 MG TABLET

pioglitazone
$12.4826per EA
High Outlier

Strength

15 mg/1

NDC

64764015104

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

1/4/2017

Active Ingredients

PIOGLITAZONE HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA021073

On Market Since

7/15/1999

Pharmacological Classes

Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for ACTOS 15 MG TABLET has been published 216 times since Nov 28, 2013, and over the history we have for it it has risen 67.8%. The table below summarizes its recorded NADAC range and movement.

Current price$12.4826 per EA
All-time high$12.4826 (Jan 10, 2018)
All-time low$7.4371 (Nov 28, 2013)
Median price$11.0274
Average price$10.7536
Largest weekly change+9.9% (Jan 15, 2014)
Weeks tracked216
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+67.8%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 3%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of ACTOS 15 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ACTOS 15 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $12.4826 per EA (NDC 64764015104), effective Jan 10, 2018.

How has the price of ACTOS 15 MG TABLET changed over time?

Over the history we have for it, the NADAC for ACTOS 15 MG TABLET has risen 67.8%. It has been tracked across 216 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ACTOS 15 MG TABLET?

Since Nov 28, 2013, the NADAC for ACTOS 15 MG TABLET has ranged from a low of $7.4371 (Nov 28, 2013) to a high of $12.4826 (Jan 10, 2018), with a median of $11.0274 per EA.

Are there cheaper alternatives to ACTOS 15 MG TABLET?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, ACTOS 15 MG TABLET, is $12.1190 per EA — about 3% below ACTOS 15 MG TABLET.

Who manufactures ACTOS 15 MG TABLET?

ACTOS 15 MG TABLET (NDC 64764015104) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.